At a glance
ClinicalIndex Comparison RecordN/ACompleted· 47 enrolled
Drug / intervention
Placebo vs Setraline +1 moredrug
Likely dose
Setraline 250mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Double Blind Clinical Trial of DCS for Food Anxiety for Patients With Anorexia and Bulimia Nervosa
In Brief
A clinical study evaluating Placebo vs Setraline and Setraline for Anorexia and Bulimia Nervosa. Completed, enrolled 47 participants across 1 site.
Detailed Summary
This is a pilot study investigating if cycloserine (DCS; a learning enhancement medication) augments exposure therapy for food anxiety in patients with anorexia and bulimia nervosa. The investigators expect that (a) exposure therapy will reduce anxiety (b) anxiety will be reduced more in the DCS relative to placebo condition (c) participants in the DCS condition will have a greater increase in Body Mass Index.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnorexia and Bulimia Nervosa
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2013
First PostedNov 2013
Primary CompletionFeb 2014
TodayJul 2026
First PostedNov 27, 2013
Enrollment StartFeb 1, 2013
Primary CompletionFeb 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 12.6 years ago
Interventions
Placebo vs Setralinedrug
Placebo
Setralinedrug
250mg DCS